Buscar resultados de ensayos clínicos
Anthrax - 40 Studies Found
| Estado | Estudiar |
| Completed |
Nombre del estudio: Safety, Tolerability, and PK of Single IM Doses of ETI-204 in Adult Volunteers Condición: Inhalational Anthrax Fecha: 2013-08-02 Intervenciones:
|
| Completed |
Nombre del estudio: Safety, Tolerability and PK of Repeat Administration of IV ETI-204 Condición: Inhalational Anthrax Fecha: 2013-08-02 Intervenciones:
|
| Completed |
Nombre del estudio: A Study to Assess the Safety, Tolerability and PK of a Single IV Dose of ETI-204 in Adult Volunteers Condición: Inhalational Anthrax Fecha: 2013-08-02 Intervenciones:
|
| Completed |
Nombre del estudio: CDC Anthrax Vaccine Clinical Trial Condición: Healthy Fecha: 2005-07-06 Intervenciones: Biological: BioThrax or Anthrax Vaccine Adsorbed |
| Completed |
Nombre del estudio: An Open-label, Nonrandomized Study to Evaluate the Safety and Immunogenicity of Raxibacumab With Reinjection Condición: Therapeutic Treatment of Inhalation Anthrax Fecha: 2013-12-16 Intervenciones: Biological: Raxibacumab Raxibacumab will be supplied in 50 milliliter (mL) sterile, single-use vials con |
| Active, not recruiting |
Nombre del estudio: Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed Condición: Infections, Bacterial Fecha: 2015-01-12 Intervenciones:
|
| Completed |
Nombre del estudio: VHA Clinicians and Bioterror Events: Interactive Web-based Learning Condición:
Fecha: 2005-07-20 Intervenciones: Behavioral: BioCASES and BioTESTS |
| Completed |
Nombre del estudio: Special Drug Use Investigation of Ciproxan Injection in Pediatrics Condición: Cystitis / Pyelonephritis / Cystic Fibrosis / Anthrax Fecha: 2015-09-18 Intervenciones: Drug: Cipro (Ciprofloxacin, BAYQ3939) Treatment parameters following the physician's decision based on t |
| Not yet recruiting |
Nombre del estudio: An Open Label, Phase IV Study Evaluating the Clinical Benefit, Safety and Pharmacokinetics of Raxibacumab in Subjects Exposed to Bacillus Anthracis Condición: Infections, Bacterial Fecha: 2014-05-15 Intervenciones: Other: Collection of samples Whenever possible serum sampl |
| Completed |
Nombre del estudio: Anthrax AV7909 Boost Evaluation Study Condición: Anthrax Fecha: 2025-09-05 Intervenciones: AV7909 Anthrax Vaccine is being developed by Emergent Product Development Gaithersburg Inc. (Emergent) for PEP of disease in persons 18 through 65 yea |